TWST

Twist Bioscience (TWST)

Twist Bioscience Corporation

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:TWST

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/06/07	22 : 57	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:TWST	Twist Bioscience Corporation
2024/06/07	04 : 31	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:TWST	Twist Bioscience Corporation
2024/06/07	04 : 24	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:TWST	Twist Bioscience Corporation
2024/06/07	04 : 20	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:TWST	Twist Bioscience Corporation
2024/06/07	04 : 18	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:TWST	Twist Bioscience Corporation
2024/06/07	04 : 15	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:TWST	Twist Bioscience Corporation
2024/06/06	21 : 00	Business Wire	Twist Bioscience Publishes Preclinical Data Detailing Discovery of Antibody Targeting Emerging Checkpoint Inhibitor	NASDAQ:TWST	Twist Bioscience Corporation
2024/06/04	21 : 00	Business Wire	Twist Bioscience Announces Participation in Department of Commerce Consortium Dedicated to AI Safety	NASDAQ:TWST	Twist Bioscience Corporation
2024/06/04	01 : 22	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:TWST	Twist Bioscience Corporation
2024/05/24	04 : 20	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:TWST	Twist Bioscience Corporation
2024/05/23	21 : 00	Business Wire	Twist Bioscience to Present at Upcoming Investor Conferences	NASDAQ:TWST	Twist Bioscience Corporation
2024/05/13	21 : 00	Business Wire	Twist Bioscience Launches Multiplexed Gene Fragments to Enable High-throughput Screening Applications	NASDAQ:TWST	Twist Bioscience Corporation
2024/05/08	21 : 00	Business Wire	Twist Bioscience Corporation Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)	NASDAQ:TWST	Twist Bioscience Corporation
2024/05/08	05 : 05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TWST	Twist Bioscience Corporation
2024/05/08	05 : 05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TWST	Twist Bioscience Corporation
2024/05/08	05 : 05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TWST	Twist Bioscience Corporation
2024/05/03	05 : 05	Business Wire	Twist Bioscience Reports Fiscal Second Quarter 2024 Financial Results	NASDAQ:TWST	Twist Bioscience Corporation
2024/04/18	21 : 00	Business Wire	Twist Bioscience to Report Fiscal 2024 Second Quarter Financial Results on Thursday, May 2, 2024	NASDAQ:TWST	Twist Bioscience Corporation
2024/03/28	21 : 00	Business Wire	Twist Bioscience Launches Pangenome Spike-in Exome Panel to Enable Advancement of Research for Diverse Populations	NASDAQ:TWST	Twist Bioscience Corporation
2024/03/09	06 : 05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TWST	Twist Bioscience Corporation
2024/03/09	06 : 05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TWST	Twist Bioscience Corporation
2024/03/09	06 : 05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TWST	Twist Bioscience Corporation
2024/03/09	06 : 05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TWST	Twist Bioscience Corporation
2024/03/09	06 : 05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TWST	Twist Bioscience Corporation
2024/03/07	05 : 32	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:TWST	Twist Bioscience Corporation
2024/03/07	05 : 26	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:TWST	Twist Bioscience Corporation
2024/03/07	05 : 20	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:TWST	Twist Bioscience Corporation
2024/03/07	05 : 18	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:TWST	Twist Bioscience Corporation
2024/03/07	05 : 17	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:TWST	Twist Bioscience Corporation
2024/03/05	22 : 00	Business Wire	Twist Bioscience Launches IVDR-compliant Precision Dx Products for Whole Exome Sequencing	NASDAQ:TWST	Twist Bioscience Corporation